A research team at Washington University in St. Louis tested a psychedelic that acts on serotonin. Serotonin helps control the widening and narrowing of blood vessels, so the team wanted to see if blood-flow signals still match neural activity.
In mice given the drug, blood flow did not change in the usual way when neurons were active. A second medication that blocks a specific serotonin receptor removed those unusual blood-flow effects. The researchers then used psilocybin in more mouse experiments and reanalyzed human fMRI data; both showed comparable changes. The finding means blood flow–based scans may not always show true neural activity after psychedelics.
Difficult words
- psychedelic — a drug that changes perception and thinking
- serotonin — a chemical in the body that affects blood vessels
- receptor — a protein on cells that receives signals
- psilocybin — a psychedelic compound found in some mushrooms
- blood flow — movement of blood through body vesselsblood-flow
- neural — related to nerves or brain cells
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Related articles
Targeting a brain circuit to reduce opioid relapse
Researchers at Washington State University found that lowering activity in a specific brain connection cut heroin-seeking in a preclinical model. The study identifies a pathway between the prelimbic cortex and the paraventricular thalamus and tests two ways to reduce its activity.
Study finds Abbott-Bioline malaria test gives many false negatives
A study on the Thailand–Myanmar border found the Abbott-Bioline rapid malaria test missed many infections. Researchers call it “not fit for purpose”; WHO and the manufacturer are reviewing the test and further studies are under way.
Untreated Sleep Apnea Speeds Heart Aging and Raises Death Risk
A laboratory study using a long-term mouse model finds that untreated obstructive sleep apnea — recreated by repeated drops in oxygen during sleep — leads to faster cardiovascular aging and higher mortality. Researchers call for early screening and treatment.
New device measures blood viscosity in real time
Researchers at the University of Missouri created a non-invasive device that monitors blood viscosity and density in real time using ultrasound and software. It can read blood without drawing samples and may help in diseases like sickle cell.
Most US drug trials do not mirror racial and ethnic diversity
A study of pivotal trials used to approve new drugs found only a small share reflect the United States racial and ethnic makeup. The review shows underrepresentation of Black and Hispanic people and urges more diversity earlier in development.
AI coach helps medical students learn suturing
Researchers at Johns Hopkins developed an explainable AI tool that gives immediate text feedback to medical students practicing suturing. A small randomized study found faster learning for students with prior experience; beginners showed less benefit.